WVP
SBBP

Worth Venture Partners’s Strongbridge Biopharma plc. SBBP Stock Holding History

Worth Venture Partners’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-550,196
Closed -$1.52M – 135
2021
Q1 		$1.52M Buy
550,196
+101,150
+23% +$305K 0.74% 38
2020
Q4 		$1.09M Buy
449,046
+222,326
+98% +$536K 0.86% 36
2020
Q3 		$476K Buy
226,720
+41,567
+22% +$140K 0.39% 64
2020
Q2 		$700K Buy
+185,153
New +$555K 0.34% 41

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Worth Venture Partners's SBBP Position: Q2 2021 in Review

Worth Venture Partners sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 550,196 shares — an estimated $1.52M sold.

Worth Venture Partners first reported a position in SBBP in Q2 2020 and held it in 4 quarters. The position peaked at $1.52M in Q1 2021. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Worth Venture Partners reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Worth Venture Partners sold 550,196 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $1.52M.
  • Worth Venture Partners first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 4 quarters.
  • Worth Venture Partners's Strongbridge Biopharma plc. position peaked at $1.52M in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Worth Venture Partners's 13F filing for Q2 2021, filed 16 Aug 2021.